CD33 and Alzheimer disease: Furthermore, a risk allele of rs3865444 was associated with reduced Aβ1–42 internalization, and an increase in fibrillar amyloid, and neuritic amyloid pathology in AD patients, supporting the involvement of CD33 in the modulation of Aβ clearance (Bradshaw et al., 2013).